Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.
Nishimura R, Tominaga T, Mitsuyama S, Aoyama H, Asaga T, Ohno S, Okuyama N, Kimura M, Iwase H, Kanda K, Koga T, Shiba E, Ikeda T. Nishimura R, et al. Among authors: mitsuyama s. Anticancer Res. 2004 May-Jun;24(3b):2085-91. Anticancer Res. 2004. PMID: 15274405 Free article. Clinical Trial.
Breast cancer in Japanese men: does sex affect prognosis?
Anan K, Mitsuyama S, Nishihara K, Abe Y, Iwashita T, Ihara T, Tamae K, Ono M, Toyoshima S. Anan K, et al. Among authors: mitsuyama s. Breast Cancer. 2004;11(2):180-6. doi: 10.1007/BF02968299. Breast Cancer. 2004. PMID: 15550865
Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II study.
Nishimura R, Ogawa T, Kato M, Tanaka M, Hamada Y, Shibata T, Ishikawa E, Koga T, Mitsuyama S, Tamura K; Kyushu Breast Cancer Study Group (KBC-SG). Nishimura R, et al. Among authors: mitsuyama s. Chemotherapy. 2005 May;51(2-3):126-31. doi: 10.1159/000085620. Epub 2005 May 9. Chemotherapy. 2005. PMID: 15886472 Clinical Trial.
Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K, Mitsuyama S, Kuga H, Saimura M, Tanabe Y, Suehara N, Matsunaga H, Nishihara K, Abe Y, Iwashita T, Ihara T, Tamae K, Ono M, Toyoshima S. Anan K, et al. Among authors: mitsuyama s. Surgery. 2006 May;139(5):624-9. doi: 10.1016/j.surg.2005.11.007. Surgery. 2006. PMID: 16701094
136 results